International Journal of Medical Imaging

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Evaluated the Correlation Between Serum Ferritin and Iron Overload of Liver, Spleen and Heart in β-Thalassemia Major Patients by MRI T2* Method

β-Thalassemia major often results in an excess of iron in the body due to frequent blood transfusions and enhanced absorption of iron in the gastrointestinal tract. Early detection of this condition and administering sufficient iron chelator therapy can significantly decrease the risk of complications and fatalities resulting from iron overload. MRI (Magnetic Resonance Imaging) T2* is an accurate non-invasive method for assessing organ iron overload in β-Thalassaemia major patients. This study evaluated the correlation between serum ferritin and iron overload of liver, spleen, and heart in β -Thalassaemia major patients by MRI T2* method. The design was a cross-section, descriptive study. We used MRI-T2* to evaluate the correlation between serum ferritin and iron overload of liver, spleen, and heart in 24 Thalassaemia major patients admitted in Cho Ray hospital from 10/2013 to 1/2014, using a 1.5T MRI system (Siemens) with a body coil. T2* measurements were taken in the liver, spleen, and myocardium using different gradient echo pulse sequences. T2* values were calculated within homogeneous regions of interest (ROI) in the liver avoiding major blood vessels, spleen, and the entire thickness of the interventricular septum in the myocardium. Pearson correlation coefficient was used to evaluate correlations in the study with a significance threshold of p < 0.05 using SPSS 16.0 software. As results, moderate negative correlation between serum ferritin and liver, spleen MRI T2* relaxation time (r = 0.57 and 0.755) and a weak negative correlation between serum ferritin and heart MRI T2* relaxation time (r = 0.303). Liver and heart MRI T2* readings were poorly correlated (r = 0.28). In conclusion, MRI T2* is useful to evaluate the iron overload status in β thalassemia patients.

Serum Ferritin, MRI T2*, β -Thalassemia Major

Nga Thi Ho Nguyen, Phuoc Van Le, Phuoc Thanh Bui, Dung Van Le, Lam Hoang Nguyen, et al. (2023). Evaluated the Correlation Between Serum Ferritin and Iron Overload of Liver, Spleen and Heart in β-Thalassemia Major Patients by MRI T2* Method. International Journal of Medical Imaging, 11(1), 21-24.

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Anderson LJ. Assessment of iron overload with T2* magnetic resonance imaging. Progress in cardiovascular Diseases, 2011, 54: 287-294.
2. Anderson LJ et al. Cardiovascular T2* magnetic resonance for early diagnosis of myocardial iron overload. European Heart Journal, 2001, 22: 2171-2179.
3. Andrew T2*: an ROC study. The Internet Journal of Gastroenterology, 2009, 8 (2): 1528-1532.
4. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with β – Thalassaemia major. Pediatric Radiology, 2007, 37: 183-190.
5. Azarkeivan A et al. Relation between serum ferritin and liver and heart MRI T2* in β thalassaemia major patients. Eastern Mediterranean Health Journal, 2012, 19: 727-380.
6. Casey J. Brewer et al. Spleen R2 and R2* in iron-overload patients with sickle cell disease and thalassemia major. J Magn Reson Imaging, 2009, 29 (2): 357-364.
7. Cohen AR et al. Thalassemia. Hematology (American society of Hematology Education Program). Washington DC, American Society of Hematology, 2004: 14-34.
8. Hamed EA, El Melegy NT. Renal functions in pediatric patients with β - thalassemia major: relation to chelation therapy: original prospective study. Italian Journal of Pediatrics, 2010, 6: 39.
9. Jane S Hankins, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood, 2009, 113: 4853-4857.
10. Jonh-Paul Carpenter, et al. On T2* magnetic resonance and cardia citron. Circulation, 2011, 1519-1528.
11. Kirk P et al. International reproducibility of single breath hold T2* MR for cardiac and liver iron assessment among five thalassemia centers. Journal of Magnetic Resonance Imaging, 2010, 32: 315-319.
12. Kirk P et al. Cardiac T2* magnetic resonance for the prediction of cardiac complications in thalassemia major. Circulation, 2009, 120: 1961-1968.
13. Leung AW et al. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion depend patients. Pediatric blood and cancer, 2009, 53: 1054-1059.
14. Ping Hou et al. A practical approach for a wide range of liver iron quantitation using a magnetic resonance imaging technique. Radiology research and practice, 2012, 2012: 2073-2082.
15. St pierre TG et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood, 2005, 105: 855-861.
16. Tanner MA et al. Thalassemia International Federation Heart T2* Investigators. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Hematological, 2006, 91: 1388-1391.
17. Wood JC. Diagnosis and management of transfusion iron overload: the role of imaging. PMC, 2010, 82: 1132-1135.
18. Wood JC. Magnetic resonance imaging measurement of iron overload. Current Opinion Hematology, 2007, 14: 183-190.
19. Worwood M et al. Binding of serum ferritin to concanavalin A: patients with homozygous β thalassaemia and transfusion iron overload. British Journal of Haematology, 1980, 46: 409-416.
20. Yesilipek MA. Stem cell transplantation in hemoglobinopathies. Hemoglobin, 2007, 31: 251-256.